SCHEMBL440643

SCHEMBL440643

C=C(C#N)C(=O)OCCCOC

nearest known ligand 0.58

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.58
ALDH1A1 P00352 4/20 0.58
DNM1 Q05193 2/20 0.34
THRB P10828 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2675457 0.96 TSHR (0.58) TSHRALDH1A1DNM1THRBL3MBTL1
SCHEMBL28362669 0.95 TSHR (0.53) TSHRALDH1A1DNM1THRB
SCHEMBL21932826 0.95 TSHR (0.53) TSHRALDH1A1DNM1THRB
SCHEMBL20472550 0.95 TSHR (0.56) TSHRALDH1A1DNM1THRBL3MBTL1
SCHEMBL21292580 0.93 ALDH1A1 (0.71) TSHRALDH1A1DNM1THRB
SCHEMBL4578754 0.90 TSHR (0.63) TSHRALDH1A1DNM1THRB
SCHEMBL487323 0.89 TSHR (0.62) TSHRALDH1A1DNM1THRB
SCHEMBL4580407 0.86 TSHR (0.63) TSHRALDH1A1DNM1THRB
SCHEMBL1602601 0.85 TSHR (0.58) TSHRALDH1A1DNM1THRB
SCHEMBL4581421 0.84 TSHR (0.61) TSHRALDH1A1DNM1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12606719-B2 Methods and compositions comprising biodegradable cyanoacrylates FEMASYS INC. (US) 2026-04-21 US claimed
US-20260062590-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS FEMASYS INC (US) 2026-03-05 US claimed
EP-4613213-A2 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS Femasys, Inc. (US) 2025-09-10 EP claimed
EP-3579890-B1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FEMASYS INC (US) 2025-06-18 EP claimed
US-20230390105-A1 METHODS AND DEVICES FOR CONTROLLED DELIVERY POINTILLIST GLOBAL MACRO SERIES OF POINTILLIST PARTNERS LLC 2023-12-07 US claimed
US-20230364304-A1 METHODS OF FORMING BONE INTERFACE SCAFFOLDS Sparta Biopharma LLC (US) 2023-11-16 US claimed
CN-115627124-A Low-whitening impact-resistant quick-drying adhesive composition and preparation method thereof 上海兰盛新材料科技有限公司 2023-01-20 CN claimed
US-11364324-B2 Methods of forming bone interface scaffolds SPARTA BIOPHARMA INC. (US) 2022-06-21 US claimed
US-20220054709-A1 METHODS OF FORMING BONE INTERFACE SCAFFOLDS SPARTA BIOPHARMA INC. 2022-02-24 US claimed
EP-3941989-A1 CYANOACRYLATE ADHESIVE COMPOSITION Henkel AG & Co. KGaA (DE) 2022-01-26 EP claimed
WO-2006034157-A2 PACKAGE COMPONENTS FOR RADIOCHEMICAL STERILIZATION POLY-MED, INC. (US) 2006-03-30 WO claimed
EP-0952171-B1 Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof POLY MED INC (US) 2006-01-04 EP claimed
US-20050042197-A1 Stabilized polyester/cyanoacrylate tissue adhesive formulation POLY-MED, INC. 2005-02-24 US claimed
US-20040199207-A1 Polyester/cyanoacrylate tissue adhesive compositions POLY-MED, INC. 2004-10-07 US claimed
US-6699940-B2 Cyanoacrylate-capped heterochain polymers and tissue adhesives and sealants therefrom POLY MED, INC. 2004-03-02 US claimed
US-6632450-B1 Adherable biomaterial patches and methods for producing and for using same Gregory, Kenton 2003-10-14 US claimed
US-20030105256-A1 Cyanoacrylate-capped heterochain polymers and tissue adhesives and sealants therefrom POLY-MED, INC. 2003-06-05 US claimed
US-20030069535-A1 Stabilized polyester/cyanoacrylate tissue adhesive formulation POLY-MED, INC. 2003-04-10 US claimed
US-6413539-B1 BLOCK POLYMER POLY-MED, INC. 2002-07-02 US claimed
EP-0952171-A2 Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof Poly-Med Inc. (US) 1999-10-27 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062590-A1 METHODS AND COMPOSITIONS COMPRISING BIODEGRADABLE CYANOACRYLATES FOR MEDICAL APPLICATIONS PGF, ACR, FGB TSHR 2244/4885ALDH1A1 247/4885DNM1 4723/4885
US-12606719-B2 Methods and compositions comprising biodegradable cyanoacrylates MKI67, ACR, PGF TSHR 3297/4885ALDH1A1 159/4885DNM1 4697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.